Sabby Management, LLC Kempharm, Inc Transaction History

Sabby Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.12 - $5.62 $735,799 - $1 Million	-178,592 Reduced 71.84%	70,000 $321,000
Q3 2022 Nov 14, 2022	SELL	$4.5 - $6.85 $206,527 - $314,380	-45,895 Reduced 15.58%	248,592 $1.55 Million
Q2 2022 Aug 15, 2022	BUY	$4.02 - $5.21 $143,542 - $186,033	35,707 Added 13.8%	294,487 $1.31 Million
Q1 2022 May 16, 2022	BUY	$5.0 - $9.26 $1.19 Million - $2.21 Million	238,780 Added 1193.9%	258,780 $1.3 Million
Q4 2021 Feb 14, 2022	SELL	$7.6 - $10.26 $163,635 - $220,908	-21,531 Reduced 51.84%	20,000 $174,000
Q3 2021 Nov 15, 2021	SELL	$8.72 - $13.31 $1.14 Million - $1.74 Million	-130,632 Reduced 75.88%	41,531 $387,000
Q2 2021 Aug 16, 2021	BUY	$8.52 - $15.47 $1.47 Million - $2.66 Million	172,163 New	172,163 $2.21 Million

116

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.